-2.2 C
London
Saturday, December 10, 2022

Schedule Your Presentation to Thousands of Investors Now

Med, Biotech & Pharma

Emerging Growth Medical, Biotechnology and Pharmaceutical Companies

Disease Detection Medical Equipment

Great Basin Scientific, Inc. (OTCQB: GBSN) Soars 66.67% After Completing Clinical Trial, Submitting FDA...

Great Basin Scientific, Inc. (OTCQB: GBSN) is engaged as a molecular diagnostic testing company, which manufacturers infection test devices for medical facilities. Shares of...
PharmaCyte Biotech, Inc. (OTCQB: PMCB)

PharmaCyte Biotech, Inc. (PMCB) Receives CE Mark for Licensed COVID-19 Molecular Tests

Miami, FL – July 29, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging...
(OTCQB: CYDY)

Novant Health Initiates Phase 2 COVID-19 Trial with CytoDyn’s (OTCQB: CYDY) Leronlimab

Miami, FL – April 7, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

As Kite seeks FDA approval on their Tecartus for Adult patients, smaller CAR-T Player...

Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer with potential blockbuster prospects in immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets.

The Sectors to be invested in for the remainder of 2020

On the healthcare front, Edesa Biotech (NASDAQ: EDSA) has an interesting chart. Between $8 and 9.00 per share sits a major pivot created on August 11, 2020. If the stock can maintain above it, the ceiling will become the floor and the stock will have room to $19.00 per share.

Cannabis Retailer May List on NASDAQ with Big Retail Backing

For investors looking for companies in an earlier stage of development that may see further growth this year, the author could have also made note of companies like CLS Holdings USA, Inc. (OCTQB:CLSH;CSE:CLSH). CLS Holdings USA, Inc. (OTCQB: CLSH; CSE:CLSH)  is a vertically integrated cannabis producer and retailer offering a wide variety of cannabis products through two subsidiaries: Oasis Cannabis and City Trees. The Company holds a U.S. Patent for a proprietary extraction and conversion methodology, which delivers products with a higher level of quality and consistency.

Just Released – Mateon Therapeutics (OTCQB: MATN) – A Video Update on their Progress...

Miami, FL – May 4, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

Dr. Dominick Monaco of CLS Holdings (OTCQB: CLSH) on Advancements in Extraction & the...

One of the essential elements in the extracts vertical advancements is the adoption of good manufacturing practices. According to the World Health Organization website, “Good Manufacturing Practice (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use.”
Emerald Organic Products Inc. (EMOR)

Emerald Organic Products Inc. (EMOR) Signs Joint Venture Agreement with Deposits.com

Miami, FL – August 12, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for...

Investing in the Vitamin Industry through DNA Genetics

An article in Banyan Hill discussed a better way to buy Vitamins.  A company called Baze, prides themselves on being the only FDA approved at-home blood nutrient test.  They...

Latest News